Tennessee · 114

SB 1495

Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.

Bill record: Open States bulk CSV (bills/votes) CC0-1.0

Summary AI-generated

Tennessee SB 1495 amends TCA Title 20 and Title 33 to add Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies eligible for release by the attorney general regarding pending or future opioid claims.

Software-generated, grounded only in the bill's own fields (it does not invent outcomes, amounts, or dates). Provenance: Open States bulk CSV (bills/votes) CC0-1.0 GovTally LLM enrichment (local oMLX)

Issue tags AI-classified

Classified by a local model from the bill's text; confidence shown. GovTally LLM enrichment (local oMLX)

Sponsors

Roll-call votes on this bill

QuestionChamberResultYeaNayOtherDateSource
FLOOR VOTE: REGULAR CALENDAR PASSAGE ON THIRD CONSIDERATION 4/16/2026 Passed (1) lower pass 0 0 1 Apr 16, 2026 Open States bulk CSV (bills/votes) CC0-1.0
FLOOR VOTE: Motion to Adopt 2/19/2026 Passed (1) upper pass 0 0 0 Feb 19, 2026 Open States bulk CSV (bills/votes) CC0-1.0
SENATE JUDICIARY COMMITTEE: Recommended for passage, refer to Senate Calendar… upper pass 0 0 0 Feb 10, 2026 Open States bulk CSV (bills/votes) CC0-1.0